- Country: USA
- Summary: Bioruptor Plus Sonication Device
- UST Ref No: 102160027
- Deadline: 12 Jun 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 75N91024Q00106
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), ), Laboratory of Biochemistry and Molecular Biology (LBMB) in the Center for Cancer Research (CCR) plans to procure, on a sole source basis, Bioruptor Plus sonication device from:
Diagenode, Inc,400 Morris Avenue, Suite 101, Denville, NJ 07834
The response close date of the notice for this requirement is in accordance with FAR 5.203(b). This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and will be made pursuant to the authority in FAR Part 13.106-1 (b)(1) and is exempt from the requirements of FAR Part 6. The North American Industry Classification System code is 334516 and the business size standard is 1000 employees.
A replacement device is being requested for LBMB-s broken Bioruptor Plus sonication device. LBMB market research reveals it is not possible to utilize another platform/device and achieve adequate results consistent with past performance. The NCI has spent time and effort optimizing techniques and protocols of use of the instrument, which makes it not possible to utilize another device and obtain satisfactory results. Several features of the Bioruptor are critical to meet LBMB research requirements, in particular the power level achieved using the Bioruptor cannot be met by competing devices and is required for chromatin shearing of fission yeast. From discussion with colleagues, internet research, on site demonstrations, and discussions with company representatives, LBMB has concluded that no other company or small business can provide a similar device capable of achieving similar or adequate results. This equipment is manufactured solely through Diagenode and is not available through other vendors. Thus, market research concludes that there are currently no other companies that can competitively offer this device.
This notice is not a request for competitive quot... - Documents:
SON--Bioruptor-Plus--NOI-SS.docx
NOI-Sole-Source--Bioruptor-Plus.docx
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINBioruptor Plus Sonication Device - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF, a Government sector organization in USA, has announced a new tender for Bioruptor Plus Sonication Device. This tender is published on USARFP under UST Ref No: 102160027 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-06-12.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
